Control of Myopia Using Novel Spectacle Lens Designs

Launched by SIGHTGLASS VISION, INC. · Aug 7, 2018

Keywords

ClinConnect Summary

This clinical trial is studying a new type of eyeglass lens designed to help slow down the worsening of nearsightedness, also known as myopia, in children. The study will last for three years and involves children aged 6 to 10 who have certain levels of nearsightedness. Participants will need to be willing to wear the special glasses provided and will not be allowed to use contact lenses during the trial.

To be eligible, children must have a specific level of nearsightedness (between -0.75 and -4.50) and both eyes should not differ too much in strength (less than 1.50). Children who have worn contact lenses, bifocals, or other treatments for myopia before are not eligible to join. Throughout the trial, participants will have regular check-ups to monitor their eye health and how well the new lenses are working. This study is currently not recruiting new participants, but it aims to understand if these new lenses can effectively help manage myopia in children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children 6-10 years of age (day prior to 10th birthday) at time of informed consent/assent
• • SER error between -0.75 and -4.50 D
• • SER power between the two eyes must be less than or equal to 1.50 D
• • Willingness to participate in the trial for 3 years without content lens wear
• Exclusion Criteria:
• • Previous or current use of contact lenses
• • Previous or current use of bifocals, progressive addition spectacles lenses
• • Previous or current use of myopia control treatment
• • Astigmatism worse then -1.25 DC in either eye